Ying-Xin Fan
FDA investigator
Appears on 2 documents from 2023 to 2025, mostly at sites in China. Most often cites written procedures; deviations (21 CFR 211.100).
- 2
- Documents on file
- 5.0
- Observations per 483
- 2023
- First seen
- 2025
- Most recent
What they cite most
From 10 observations- 21 CFR 211.100Written procedures; deviations2
- 21 CFR 211.113Control of microbiological contamination1
- 21 CFR 211.160General requirements1
- 21 CFR 211.180General requirements1
- 21 CFR 211.22Responsibilities of quality control unit1
- 21 CFR 211.42Design and construction features1
Activity by year
2023: 1, 2025: 1
Where
China 1 · Germany 1
Often inspects with
Is Ying-Xin Fan coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2025-03-21 | 483 Teva Biotech GmbHMar 21, 2025 · Ulm, Germany | Ulm, Germany | 7 | |
| 2023-05-26 | 483 Suzhou Union Biopharm Co., Ltd.May 26, 2023 · Suzhou, China | Suzhou, China | 3 |
About this profile
What does Ying-Xin Fan inspect?
Ying-Xin Fan appears on 2 documents on file covering 2 sites, mostly in China.
What do they cite most often?
21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 211.113 and 21 CFR 211.160.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Ying-Xin Fan is dated Mar 21, 2025.